Stay updated on IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now indicates that MOR106 development in atopic dermatitis was terminated for futility, with an updated study status.SummaryDifference0.3%

- Check33 days agoChange Detected- Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.SummaryDifference2%

- Check40 days agoChange DetectedRemoved several MedlinePlus topics and added a new revision tag (v3.1.0), indicating a scope reduction in topics with an updated version.”}{}-1-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0-0SummaryDifference0.3%

- Check54 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as new content related to drug safety and counterfeit drugs. Notably, several locations in Poland and Germany have been reintroduced with corrected spellings.SummaryDifference5%

Stay in the know with updates to IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.